PE106998A1 - Composiciones oftalmicas - Google Patents
Composiciones oftalmicasInfo
- Publication number
- PE106998A1 PE106998A1 PE1997000898A PE00089897A PE106998A1 PE 106998 A1 PE106998 A1 PE 106998A1 PE 1997000898 A PE1997000898 A PE 1997000898A PE 00089897 A PE00089897 A PE 00089897A PE 106998 A1 PE106998 A1 PE 106998A1
- Authority
- PE
- Peru
- Prior art keywords
- ophthalmic compositions
- glaucoma
- treatment
- acceptable salt
- xanthan gum
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
QUE COMPRENDE UNA SOLUCION HIPOTONICA DE: A) 0,1% A 2 % DE GOMA DE XANTANO; Y B) 0,5% A 5% DE UN INHIBIDOR TOPICO DE LA CARBONICO ANHIDRASA DE FORMULA (I), UN DIASTEREOMERO INDIVIDUAL, UN ENANTIOMERO INDIVIDUAL O UNA MEZCLA DE LOS MISMOS, O UNA SAL OFTALMOLOGICAMENTE ACEPTABLE DE LOS MISMOS, DONDE A ES CARBONO O NITROGENO; Z ES -NHR U -OR; R ES ALQUILO C1-C6, DE CADENA LINEAL O RAMIFICADA; R1 ES HIDROGENO, ALQUILO C1-C3 O ALCOXI C1-C4; Y X ES -SO2- o -C(O)-. DICHA COMPOSICION COMPRENDE ADICIONALMENTE APROXIMADAMENTE DE 0,01% A 1% DE UN AGENTE BLOQUEANTE DE RECEPTORES �-ADRENERGENICOS O DE UNA SAL OFTALMOLOGICAMENTE ACEPTABLE DEL MISMO. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA TRATAR LA HIPERTENSION OCULAR O EL GLAUCOMA, QUE COMPRENDE LA ADMINISTRACION OCULAR TOPICA, A UN PACIENTE QUE NECESITE DICHO TRATAMIENTO, DE UNA DOSIS UNITARIA DE LA COMPOSICION DESCRITA ANTERIORMEMTE
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9612658A FR2754712B1 (fr) | 1996-10-17 | 1996-10-17 | Compositions ophtalmiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE106998A1 true PE106998A1 (es) | 1999-01-23 |
Family
ID=9496748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1997000898A PE106998A1 (es) | 1996-10-17 | 1997-10-10 | Composiciones oftalmicas |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6264935B1 (es) |
| EP (1) | EP0932389B1 (es) |
| JP (1) | JP2001508035A (es) |
| AT (1) | ATE223200T1 (es) |
| AU (1) | AU715223B2 (es) |
| CA (1) | CA2269552A1 (es) |
| DE (1) | DE69715228T2 (es) |
| ES (1) | ES2183148T3 (es) |
| FR (1) | FR2754712B1 (es) |
| HR (1) | HRP970552A2 (es) |
| PE (1) | PE106998A1 (es) |
| WO (1) | WO1998017249A1 (es) |
| ZA (1) | ZA979219B (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6261547B1 (en) | 1998-04-07 | 2001-07-17 | Alcon Manufacturing, Ltd. | Gelling ophthalmic compositions containing xanthan gum |
| US6174524B1 (en) | 1999-03-26 | 2001-01-16 | Alcon Laboratories, Inc. | Gelling ophthalmic compositions containing xanthan gum |
| CA2386822A1 (en) | 1999-11-01 | 2001-05-10 | Alcon, Inc. | Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum |
| PL199321B1 (pl) | 2000-07-28 | 2008-09-30 | Alcon Inc | Kompozycje farmaceutyczne zawierające tobramycynę i gumę ksantanową |
| US20040067992A1 (en) * | 2001-08-10 | 2004-04-08 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| PT1545548E (pt) * | 2002-08-30 | 2010-09-02 | Nycomed Gmbh | Utilização da combinação de ciclesonida e anti-histamínicos para o tratamento de rinite alérgica |
| EP1572217B1 (en) * | 2002-12-12 | 2008-08-20 | Nycomed GmbH | Combination medicament of r,r-formoterol and ciclesonide |
| PL1670482T5 (pl) * | 2003-09-16 | 2022-10-03 | Covis Pharma Gmbh | Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego |
| CA2563556C (en) * | 2004-04-20 | 2013-01-29 | Altana Pharma Ag | Use of ciclesonide for the treatment of respiratory diseases in a smoking patient |
| JP4948176B2 (ja) | 2004-09-28 | 2012-06-06 | 千寿製薬株式会社 | キサンタンガムおよびアミノ酸を含有する眼科用組成物 |
| CN101212960B (zh) * | 2005-07-11 | 2011-04-13 | 千寿制药株式会社 | 包括黄原胶和萜类化合物的滴眼制剂 |
| WO2007075720A2 (en) * | 2005-12-19 | 2007-07-05 | Comentis, Inc. | Topical mecamylamine formulations for ocular administration and uses thereof |
| JP5244584B2 (ja) | 2006-03-23 | 2013-07-24 | 千寿製薬株式会社 | キサンタンガムおよびブドウ糖を含有する眼科用組成物 |
| EP2050449A4 (en) | 2006-07-31 | 2010-10-06 | Senju Pharma Co | AQUEOUS LIQUID PREPARATION CONTAINING AN AMIDE |
| US20110117189A1 (en) * | 2008-07-08 | 2011-05-19 | S.I.F.I. Societa' Industria Farmaceutica Italiana S.P.A. | Ophthalmic compositions for treating pathologies of the posterior segment of the eye |
| MX2016006256A (es) * | 2013-11-15 | 2016-09-07 | Teva Pharma | Tratamiento de glaucoma usando laquinimod. |
| EA034839B1 (ru) * | 2014-10-20 | 2020-03-26 | Сентисс Фарма Прайвет Лимитед | Офтальмологический раствор |
| IT202000002296A1 (it) * | 2020-02-06 | 2021-08-06 | Sifi Spa | Formulazioni topiche oftalmiche a base di xantano con ridotta posologia |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4136178A (en) | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Locust bean gum therapeutic compositions |
| US4136173A (en) | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Mixed xanthan gum and locust beam gum therapeutic compositions |
| US4136177A (en) | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Xanthan gum therapeutic compositions |
| US5157044A (en) | 1983-02-04 | 1992-10-20 | University Of Iowa Research Foundation | Analogs of carbonic anhydrase inhibitors and their use as topical IOP inhibitors |
| US4863922A (en) | 1984-12-12 | 1989-09-05 | Merck & Co., Inc. | Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| US4876271A (en) | 1988-12-20 | 1989-10-24 | Merck & Co., Inc. | Substituted thieno[3,2-b]thiophene-2-sulfonamides as topically active carbonic anhydrase inhibitors |
| US4929549A (en) | 1989-02-08 | 1990-05-29 | Merck & Co., Inc. | 5-carbamoylthieno[2,3-b]thiophene-2-sulfon-amides as topically active carbonic anhydrase inhibitors |
| US5120757A (en) | 1989-07-31 | 1992-06-09 | Merck & Co., Inc. | Substituted aromatic sulfonamides as antiglaucoma agents |
| FR2657018A1 (fr) | 1990-01-12 | 1991-07-19 | Merck Sharp & Dohme | Composition ophtalmique fluide a base de microparticules lipidiques contenant au moins un principe actif et son procede de preparation. |
| US5055480A (en) | 1990-03-19 | 1991-10-08 | Research Corporation Technologies, Inc. | Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors |
| US5059613A (en) | 1990-03-19 | 1991-10-22 | Research Corporation Technologies, Inc. | Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors |
| US5242937A (en) | 1990-03-19 | 1993-09-07 | Research Corporation Technologies, Inc. | Topically active ocular thiadiazole sulfonamide carbonic anhydrase inhibitors |
| IE911192A1 (en) | 1990-04-12 | 1991-10-23 | Merck & Co Inc | Substituted aromatic sulfonamides as antiglaucoma agents |
| CA2040460C (en) | 1990-05-01 | 1997-06-10 | Tacey X. Viegas | Drug delivery with thermoreversible gels |
| US5091409A (en) | 1990-05-17 | 1992-02-25 | Merck & Co., Inc. | 4-alkylamino-6-(C3-5 -hydrocarbyl)thieno[2,3-B]thiopyran-2-sulfonamide-7,7-dioxides |
| US5093332A (en) | 1990-10-01 | 1992-03-03 | Merck & Co., Inc. | Substituted thieno(2,3-b)(1,4)thiazine-6-sulfonamides as antiglaucoma agents |
| DE69212850T2 (de) | 1991-01-15 | 1997-03-06 | Alcon Lab Inc | Verwendung von Karrageenan in topischen ophthalmologischen Zusammensetzungen |
| JP2536806B2 (ja) * | 1991-03-27 | 1996-09-25 | アルコン ラボラトリーズ インコーポレイテッド | ゲル化多糖類と微粉砕された薬剤担体とを組み合わせた局部眼科用組成物 |
| US5318780A (en) * | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
| WO1994006411A1 (en) | 1992-09-17 | 1994-03-31 | Alcon Laboratories, Inc. | Topical carbonic anhydrase inhibitor composition |
| SE9301877D0 (sv) * | 1993-06-02 | 1993-06-02 | Kabi Pharmacia Ab | In situ gel for therapeutic use |
| AU5114499A (en) * | 1998-07-21 | 2000-02-14 | Merck & Co., Inc. | Ophthalmic compositions for treating ocular hypertension |
-
1996
- 1996-10-17 FR FR9612658A patent/FR2754712B1/fr not_active Expired - Fee Related
-
1997
- 1997-10-09 AT AT97911223T patent/ATE223200T1/de not_active IP Right Cessation
- 1997-10-09 WO PCT/EP1997/005678 patent/WO1998017249A1/en active IP Right Grant
- 1997-10-09 DE DE69715228T patent/DE69715228T2/de not_active Expired - Fee Related
- 1997-10-09 CA CA002269552A patent/CA2269552A1/en not_active Abandoned
- 1997-10-09 ES ES97911223T patent/ES2183148T3/es not_active Expired - Lifetime
- 1997-10-09 EP EP97911223A patent/EP0932389B1/en not_active Expired - Lifetime
- 1997-10-09 US US09/284,718 patent/US6264935B1/en not_active Expired - Fee Related
- 1997-10-09 JP JP51891698A patent/JP2001508035A/ja active Pending
- 1997-10-09 AU AU48673/97A patent/AU715223B2/en not_active Ceased
- 1997-10-10 PE PE1997000898A patent/PE106998A1/es not_active Application Discontinuation
- 1997-10-15 ZA ZA979219A patent/ZA979219B/xx unknown
- 1997-10-16 HR HR9612658A patent/HRP970552A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0932389A1 (en) | 1999-08-04 |
| WO1998017249A1 (en) | 1998-04-30 |
| CA2269552A1 (en) | 1998-04-30 |
| ZA979219B (en) | 1998-07-17 |
| US6264935B1 (en) | 2001-07-24 |
| DE69715228D1 (de) | 2002-10-10 |
| FR2754712B1 (fr) | 1999-09-03 |
| AU4867397A (en) | 1998-05-15 |
| HRP970552A2 (en) | 1998-08-31 |
| AU715223B2 (en) | 2000-01-20 |
| DE69715228T2 (de) | 2003-06-05 |
| EP0932389B1 (en) | 2002-09-04 |
| ATE223200T1 (de) | 2002-09-15 |
| ES2183148T3 (es) | 2003-03-16 |
| FR2754712A1 (fr) | 1998-04-24 |
| JP2001508035A (ja) | 2001-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2754712B1 (fr) | Compositions ophtalmiques | |
| MX9702349A (es) | Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma. | |
| BR9813767A (pt) | Processo e composição para tratar glaucoma de glc1a | |
| RU95101048A (ru) | Производные пролинамида, фармкомпозиция на их основе | |
| EP1225168A3 (en) | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension | |
| CA2183315A1 (en) | Novel Mercaptoacetylamido 1,3,4,5-Tetrahydro-Benzo[c]azepin-3-One Disulfide Derivatives Useful as Inhibitors of Enkephalinase and Ace | |
| TR199901191T2 (xx) | Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�. | |
| MXPA03010146A (es) | Composiciones de lipidos hipotensivos (derivados de prostaglandina) y timolol, y metodos para usar las mismas. | |
| WO1992000287A3 (en) | Analogs of carbonic anhydrase inhibitors and their use as topical iop inhibitors | |
| ATE216889T1 (de) | Anwendung von prostagrandin-analogen für die behandlung von glaukome und okuläre hypertension | |
| ATE215821T1 (de) | Entzündungshemmende augentropfen | |
| ATE326972T1 (de) | Heilende zusammensetzung für intraokulare hypertension oder glaukom | |
| NO980058L (no) | Opthalmiske preparater | |
| SE9401087D0 (sv) | New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension | |
| EA200201234A1 (ru) | Производные сульфонамида | |
| ECSP972285A (es) | Composiciones oftalmicas | |
| DE69620573T2 (de) | Mittel zur verminderung des augeninnendrucks | |
| AU4397197A (en) | Subepithelial turbidity inhibitor | |
| CA2183320A1 (en) | Novel Mercaptoacetylamide Disulfide Derivatives Useful as Inhibitors of Enkephalinase and Ace | |
| WO2001082913A3 (en) | Use of benzamide derivatives for the treatment of high ocular tension and glaucoma | |
| EP1452522A3 (en) | Novel compounds and compositions as protease inhibitors | |
| KR950023403A (ko) | 치은증식 억제제 조성물 | |
| PE20050297A1 (es) | Combinacion oftalmica que comprende brimonidina y timolol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |